Transcept Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced Transcept management is scheduled to present at two upcoming investor conferences.
68808
Transcept Pharmaceuticals to present at two upcoming investor conferences
27383
World outlook for products incorporating nanotechnology
1365
New drug strategy master plan being crafted --
73994
GlaxoSmithKline uses clinical graphics solution developed by Insightful Corporation
24994
Pluristem Therapeutics to present at the Tel-Aviv Stock Exchange
47238
MedNest incorporates and launches PharmaNest
124569
BioAlliance Pharma announces the
147821
Pep Boys to conduct investor and analyst meetings
90632
Scientists discover potential drug delivery system
105270
EPAM Systems to participate at upcoming investor conferences
95584
Wockhardt gains on launching generic of Wellbutrin SR in US
52206
Medtronic to offer Prostiva prostate treatment from Urologix
73637
Reed Elsevier holds investor seminar on Elsevier Science & Technology and the research industry
71088
DuoCort's new form of treatment improves cardiovascular & metabolic measures:
175596
Compugen discovers cancer treatment target
128235
Advantec announces partnership with Teladoc
25962
BioElectronics Corp. to announce results from acetaminophen